1887

Abstract

SUMMARY

Protein subunit vaccines were prepared from a mixture of the haemagglutinin (HN) and fusion (F) glycoproteins of parainfluenza type 3 virus (PI-3). The glycoproteins were isolated in three different forms and characterized by their sedimentation coefficients: 30S protein micelles (a complex of several HN and F glycoproteins devoid of detergent and lipid), 18S protein-TX complexes (a complex of several glycoproteins containing the detergent Triton X-100), and 4S protein-TX complexes (probably monomers of the glycoproteins complexed to Triton X-100). These preparations were tested as vaccines in mice and lambs. The immune response in the mice was assayed both in the serum and in extracts from the lungs using an ELISA technique. Both of the multimeric complexes were highly immunogenic. The 30S protein micelles induced a high antibody response after two injections with either 10 or 1 µg protein. The serum IgG titres reached levels of about 90 µg/ml and 40 µg/ml respectively. Similar titres were reached with the 18S protein-TX complexes. After two injections of either the 30S or the 18S complexes IgA antibody responses were detected in the lung extracts. The 4S protein-TX complexes were poor immunogens and induced low antibody responses in mice. The lambs were vaccinated with the 30S protein micelles, and the immune response was evaluated serologically and in challenge experiments. The 30S protein micelles in an oil adjuvant induced detectable serum antibody titres as well as protective immunity against the pneumonia caused by the PI-3 virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-7-1557
1983-07-01
2022-01-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/7/JV0640071557.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-7-1557&mimeType=html&fmt=ahah

References

  1. Allison A. C. 1977; Autoimmunity, genetic, immunologic, virologic and clinical aspects. In Autoimmune Diseases - Concepts of Pathogenesis and Control pp 92–139 Edited by Talal N. New York & London: Academic Press;
    [Google Scholar]
  2. Bachmayer H., Schmidt G., Liehl E. 1976; Preparation and properties of a novel influenza subunit vaccine. Post-Graduate Medical Journal 52:360–367
    [Google Scholar]
  3. Balcarova J., Helenius A., Simons K. 1981; Antibody response to spike protein vaccines prepared from Semliki Forest virus. Journal of General Virology 53:85–92
    [Google Scholar]
  4. Blikstad J. F., Markey F., Carlsson L., Persson T., Lindberg U. 1978; Selective assay of monomeric and filamentous actin in cell extract using inhibition of deoxyribonuclease I. Cell 15:935–943
    [Google Scholar]
  5. Brady M. I., Furminger I. G. 1976; A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity. Journal of Hygiene 77:173–180
    [Google Scholar]
  6. Choppin P. W., Compans R. W. 1975; Reproduction of paramyxoviruses. In Comprehensive Virology vol 4: pp 99–178 Edited by Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
    [Google Scholar]
  7. Cox J. H., Dietzchold B., Schneider L. G. 1977; Rabies virus glycoprotein. II. Biological and serological characterization. Infection and Immunity 16:743–759
    [Google Scholar]
  8. Emtage I. S., Carey N. H. 1980; The production of vaccines by recombinant DNA techniques. In New Developments with Human and Veterinary Vaccines pp 367–375 Edited by Mizrahi A., Hertman I., Klingberg M. A., Hohn A. New York: Alan R. Liss;
    [Google Scholar]
  9. Gershon R. K. 1974; T cell control of antibody production. In Contemporary Topics in Immunology vol 3: pp 140 Edited by Cooper M. D., Warner N. L. New York: Plenum Press;
    [Google Scholar]
  10. Ginsberg H. S. 1975; Subunit viral vaccines. In Viral Immunology and Immunopathology pp 317–326 Edited by Notkins A. L. New York: Academic Press;
    [Google Scholar]
  11. Gross P. A., Ennis F. A., Gaerlan P. F., Denson L. J., Denning C. R., Schiffman D. 1977; A Controlled doubleblind comparison of reactogenicity, immunogenicity and protective efficacy of whole-virus and split-product influenza vaccines in children. Journal of Infectious Diseases 36:623–632
    [Google Scholar]
  12. Heinz F. X., Kunz CH. 1980; Formation of polymeric glycoprotein complexes from a flavivirus: a tick-borne encephalitis virus. Journal of General Virology 49:125–132
    [Google Scholar]
  13. Helenius A., Simons K. 1975; Solubilization of membranes by detergents. Biochimica el biophysica acta 415:2979
    [Google Scholar]
  14. Helenius A., Von Bonsdorff C. 1976; Semliki Forest virus membrane proteins. Preparation and characterization of spike complexes soluble in detergent-free medium. Biochimica et biophysica acta 436:895–899
    [Google Scholar]
  15. Hilleman M. R. 1976; Herpes simplex vaccines. Cancer Research 36:857–858
    [Google Scholar]
  16. Hommers G., Gilkens A., Schaake J. 1982; An indirect enzyme-linked immunoabsorbent assay for the detection of antibodies to visna viruses. Veterinary Microbiology (in press)
    [Google Scholar]
  17. Hunsmann G., Schneider J., Schulz A. 1981; Immunoprevention of Friend virus-induced erythroleukemia vaccination with viral envelope glycoprotein complexes. Virology 113:602–612
    [Google Scholar]
  18. Kleid D. G., Yansura D., Small B., Dowbenka D., Moore D. M., Grubman M. J., Mckercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: response in cattle and swine. Science 214:1125–1129
    [Google Scholar]
  19. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  20. Laver G. W., Valentine R. C. 1969; Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38:105–119
    [Google Scholar]
  21. Lerner R. A., Green N., Alexander H., Liu F. T., Sutcliffe J. G., Shinnick J. M. 1981; Chemically synthesised peptides predicted from the nucleotide sequence of the hepatitis virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proceedings of the National Academy of Sciences, U. S. A 78:3403–3407
    [Google Scholar]
  22. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
  23. Luukkonen A., Gahmberg C. G., Renkonen O. 1977; Surface labeling of Semliki Forest virus glycoproteins using galactose oxidase. Virology 76:55–59
    [Google Scholar]
  24. McLean B., Sonza S., Holmes I. H. 1980; Measurement of immunoglobulin A, G and M class rotavirus antibodies in serum and mucosal secretions. Journal of Clinical Microbiology 12:314–319
    [Google Scholar]
  25. Martin R. G., Ames B. N. 1961; A method for determining the sedimentation behavior of enzymes: application to protein mixtures. Journal of Biological Chemistry 236:1372–1379
    [Google Scholar]
  26. Matlin K., Reggio H., Helenius A., Simons K. 1981; Infectious entry pathway of influenza virus in a canine kidney cell line. Journal of Cell Biology 91:601–613
    [Google Scholar]
  27. Matlin K., Reggio H., Helenius A., Simons K. 1982; Pathway of vesicular stomatitis virus entry leading to infection. Journal of Molecular Biology 156:609–631
    [Google Scholar]
  28. Morein B., Helenius A., Simons K., Pettersson R., Kaariainen L., Schirrmacher V. 1978; Effective Subunit vaccines against an enveloped animal virus. Nature, London 276:715–718
    [Google Scholar]
  29. Morein B., Sundquist B., Hoglund S., Helenius A., Simons K. 1981; Protein micelles and virosomes from the surface glycoproteins of parainfluenza 3 virus. Protides of the Biological Fluids 29:101–104
    [Google Scholar]
  30. Muller G. M., Shapira M., Arnon R. 1982; Anti-influenza response achieved by immunization with a synthetic conjugate. Proceedings of the National Academy of Sciences, U. S. A 79:569–573
    [Google Scholar]
  31. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. 1972; Isolation of paramyxovirus glycoproteins. Virology 50:640–652
    [Google Scholar]
  32. Schneider J., Falk H., Hunsmann G. 1980; Envelope polypeptides of Friend leukemia virus: purification and structural analysis. Journal of Virology 33:597–605
    [Google Scholar]
  33. Shibuta H., Kanda T., Adachi A., Yogo Y. 1979; Characterization of bovine parainfluenza virus type 3. Microbiology and Immunology 23:617–628
    [Google Scholar]
  34. Simons K., Helenius A., Leonard K., Sarvas M., Gething M. J. 1978; Formation of protein micelles from amphiphilic membrane proteins. Proceedings of the National Academy of Sciences, U. S. A 75:5306–5310
    [Google Scholar]
  35. Simons K., Helenius A., Morein B., Balcarova J., Sharp M. 1980; Development of effective subunit vaccines against enveloped viruses. In New Developments with Human and Veterinary Vaccines pp 217–228 Edited by Mizrahi A., Hertman I., Klingberg M. A., Hohn A. New York: Alan R. Liss;
    [Google Scholar]
  36. Skelly J., Howard C. R., Zuckerman A. J. 1981; Hepatitis B polypeptide vaccine in micelle form. Nature, London 280:51–54
    [Google Scholar]
  37. Tada T., Okumura K. 1979; The role of antigen-specific T cell factors in the immune response. Advances in Immunology 28:28–67
    [Google Scholar]
  38. Waller T., Lyngset A., Elvander M., Morein B. 1980; Immunological diagnosis of encephalitozoonosis from post-mortem specimens. Veterinary Immunology and Immunopathology 1:353–360
    [Google Scholar]
  39. Wells P. W., Sharp J. M., Burrels L., Rushton B., Smith W. D. 1976; The assessment in sheep of an inactivated vaccine of parainfluenza 3 virus incorporating double stranded RNA as adjuvant. Journal of Hygiene 77:255–261
    [Google Scholar]
  40. Wells P. W., Sharp J. M., Rushton B., Gilmour M. J. L., Thompson D. A. 1978; The effect of vaccination with a parainfluenza type 3 virus on pneumonia resulting from infection with parainfluenza type 3 virus and Pasteurella haemolytica. Journal of Comparative Pathology 88:253–259
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-7-1557
Loading
/content/journal/jgv/10.1099/0022-1317-64-7-1557
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error